(15:43 GMT) Unicycive Therapeutics Price Target Cut to $13.00/Share From $18.00 by Benchmark
DO Dow Jones Newswires Unicycive Therapeutics Is Maintained at Speculative Buy by Benchmark 7/1/2026, 11:43 PM GMT+8 Dow Jones Newswires UN UNCY (15:43 GMT) Unicycive Therapeutics Price Target Cut to $13.00/Share From $18.00 by Benchmark Market News TradingView Unicycive Therapeutics reports $61.4M cash balance as of June 30, 2026 Dow Jones Newswires Unicycive Therapeutics Is Maintained at Outperform by Noble Capital Markets Stocktwits UNCY Stock Clocks Worst Day In A Year — Analysts Keep Buy Ratings Despite ‘5-12 Month Delay’ In Drug Approval Dow Jones Newswires Unicycive Therapeutics Is Maintained at Buy by HC Wainwright & Co.
